Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 452, 38-39 (6 March 2008) | doi:10.1038/452038a; Published online 5 March 2008
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
- More Challenges
- Powered by:
nature jobs
Full-Professor of Heart and Thoracic Surgery (W3) (f / m)
- Friedrich-Schiller-University Jena
- Jena Germany
Business Devlopment Officer
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Neuroscience: A complex in psychosis
Solomon H. Snyder1
Abstract
The molecular basis of psychoses such as schizophrenia remains largely mysterious. The interaction between two of the brain receptors involved adds to evidence that will help in the search for explanations.
This is a story that involves three types of receptor in the brain that influence human perception and behaviour (those for the neurotransmitters dopamine, serotonin and glutamate), and the drugs that block or enhance their activity. Such drugs are used by researchers to investigate the causes of psychotic disorders such as schizophrenia, and by clinicians to treat patients.
- Solomon H. Snyder is in the Solomon H. Snyder Department of Neuroscience, Johns Hopkins School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205-2185, USA.
Email: ssnyder@jhmi.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
An emerging pathophysiologyNature News and Views (13 Feb 1997)
Research HighlightsNature Medicine News and Views (01 Mar 2008)
RESEARCH
Identification of a serotonin/glutamate receptor complex implicated in psychosisNature Letters to Editor (06 Mar 2008)
Chronic Phenethylamine Hallucinogen Treatment Alters Behavioral Sensitivity to a Metabotropic Glutamate 2/3 Receptor AgonistNeuropsychopharmacology Original Article
See all 6 matches for Research